TrademarkDir
ENZYMATIC SUBCISION AND REMODELING (ESR)
LIVE

Serial Number

90168428

Owner

ENDO OPERATIONS LIMITED

Attorney

Camille M. Miller

Filing Date

Sep 9, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ENZYMATIC SUBCISION AND REMODELING (ESR) Trademark

Serial Number: 90168428 • Registration: 6868623

ENZYMATIC SUBCISION AND REMODELING (ESR) is a trademark filed by ENDO OPERATIONS LIMITED on September 9, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ENDO OPERATIONS LIMITED (142 trademarks)

FIRST FLOOR, MINERVA HOUSE
BALLSBRIDGE, DUBLIN 4 , IE

Entity Type: 77

ENDO PHARMACEUTICALS INC. (200 trademarks)

100 PAINTERS DRIVE (ROUTES 1 AND 202)
CHADDS FORD, PA 19317

Entity Type: 03

Trademark Details

Filing Date

September 9, 2020

Registration Date

October 11, 2022

Published for Opposition

July 26, 2022

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 1, 2024 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 11, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 11, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 26, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 6, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jun 21, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 17, 2022 ERRR
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Jun 17, 2022 AAUA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2022 CNSA
USE AMENDMENT ACCEPTED
Jun 16, 2022 IUAA
ATTORNEY REVIEW COMPLETED
Mar 9, 2022 ATRV
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 9, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 7, 2022 GNFN
FINAL REFUSAL E-MAILED
Mar 7, 2022 GNFR
FINAL REFUSAL WRITTEN
Mar 7, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2022 CRFA
ASSIGNED TO LIE
Feb 1, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 28, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 3, 2021 GNRN
NON-FINAL ACTION E-MAILED
Aug 3, 2021 GNRT
NON-FINAL ACTION WRITTEN
Aug 3, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 30, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 30, 2021 ERSI
AMENDMENT TO USE PROCESSING COMPLETE
Jun 26, 2021 AUPC
USE AMENDMENT FILED
Jun 26, 2021 IUAF
TEAS AMENDMENT OF USE RECEIVED
Jun 25, 2021 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 17, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 25, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
May 25, 2021 GNSL
SUSPENSION LETTER WRITTEN
May 25, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 30, 2021 TROA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 14, 2021 ASCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 17, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 17, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 17, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 13, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2020 NWOS
NEW APPLICATION ENTERED
Sep 12, 2020 NWAP

Related Trademarks

More from this Owner

TRUDELIVERY logo

TRUDELIVERY

TRUDELIVERY logo

TRUDELIVERY

ENDO GENERICS PAR PHARMACEUTICAL logo

ENDO GENERICS PAR PHARMACEUTICAL

ENDO GENERICS PAR PHARMACEUTICAL logo

ENDO GENERICS PAR PHARMACEUTICAL

ENDO GENERICS PAR PHARMACEUTICAL logo

ENDO GENERICS PAR PHARMACEUTICAL

ENDO GENERICS PAR PHARMACEUTICAL logo

ENDO GENERICS PAR PHARMACEUTICAL